EOLS Evolus revenue climbs 116 yearoveryear in Q2 2026 but shares slip on continued losses Ideal Power IPWR Stock Public Float Strengthens 20260416 MMA Mixed Q3 revenue crashes 63 as losses widen shares barely budge RCKY Rocky Brands Inc posts 90 percent EPS beat for Q4 2025 lifting shares 383 percent in todays trading session AVAL Grupo Aval posts strong Q2 with 13 revenue growth shares climb amid positive market reaction Is Deluxe DLX a value trap or a value play Investor Concern 20260508 AGNCN AGNC Investment Corp Series C Preferred Stock posts 75 percent Q4 2025 EPS miss with shares notching a tiny gain today ELTX Elicio Therapeutics Inc narrowly tops Q4 2025 earnings estimates shares post modest 043 percent gain today Intellia Therapeutics NTLA beats Q4 estimates as revenue climbs 169 percent annually shares rise 277 percent Chimera 2029 CIMN Relative Performance Chimera 9 2029 Senior Notes Deliver 39 EPS Beat XWIN XMAX Inc reports 726 percent year over year Q4 2025 revenue growth slips 028 percent in trading GNLX Genelux Corporation rises 758 percent even as Q4 2025 loss per share misses consensus estimates